TOFA induces cell cycle arrest and apoptosis in ACHN and 786-O cells through inhibiting PI3K/Akt/mTOR pathway

He, Dejiao; Sun, Xuan; Yang, Hongxia; Li, Xiaoli; Yang, Dingping

doi:10.7150/jca.26374



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2018; 9(15):2734-2742. doi:10.7150/jca.26374 This issue Cite

Research Paper

TOFA induces cell cycle arrest and apoptosis in ACHN and 786-O cells through inhibiting PI3K/Akt/mTOR pathway

Dejiao He, Xuan Sun, Hongxia Yang, Xiaoli Li, Dingping Yang^✉

Department of Nephrology, Renmin Hospital of Wuhan University, 99 Zhang Zhidong Rd ,Wuhan, 430060, China

Citation:

He D, Sun X, Yang H, Li X, Yang D. TOFA induces cell cycle arrest and apoptosis in ACHN and 786-O cells through inhibiting PI3K/Akt/mTOR pathway. J Cancer 2018; 9(15):2734-2742. doi:10.7150/jca.26374. https://www.jcancer.org/v09p2734.htm

Other styles

Abstract

Cancer cells usually have a high requirement for fatty acids in order to meet the rapid proliferation and metabolism. Acetyl-CoA carboxylase-α(ACCA) catalyzes the carboxylation of acetyl-CoA to malonyl-CoA and has been a rate-limiting enzyme in the synthesis of long chain fatty acid and cellular energy storage. 5-tetradecyloxy-2-furoic acid (TOFA) is well known as an allosteric inhibitor of ACCA. In this study, we examined the functions of TOFA in human renal cell carcinoma (RCC) cell lines ACHN and 786-O. According to the results, TOFA inhibited ACHN and 786-O cell growth in a concentration and time dependent manner. The IC50 values of ACHN and 786-O cells were 6.06 and 5.36 µg/ml by the treatment of TOFA for 48 h, respectively. Flow cytometry analysis showed that TOFA markedly arrest cell cycle at G2/M phase and lead to cell apoptosis. In addition, Western blot results revealed that TOFA decreased the phosphorylation of proteinkinaseB(Akt), Mammalian target of rapamycin (mTOR) and p70 ribosomal protein S6 kinase (p70S6K). What's more, specific phosphoinositide 3-kinases (PI3K) phosphorylation inhibitor LY294002 potentiated TOFA anti-cancer activity. These results suggested that TOFA induces growth restraint and apoptosis via inhibiting the PI3K/Akt/mTOR pathway and TOFA may be a novel therapeutic strategy for RCC treatment.

Keywords: TOFA, Human renal cell carcinoma cell lines, Cell cycle arrest, Cell apoptosis, PI3K/Akt/mTOR

Citation styles

APA

He, D., Sun, X., Yang, H., Li, X., Yang, D. (2018). TOFA induces cell cycle arrest and apoptosis in ACHN and 786-O cells through inhibiting PI3K/Akt/mTOR pathway. Journal of Cancer, 9(15), 2734-2742. https://doi.org/10.7150/jca.26374.

ACS

He, D.; Sun, X.; Yang, H.; Li, X.; Yang, D. TOFA induces cell cycle arrest and apoptosis in ACHN and 786-O cells through inhibiting PI3K/Akt/mTOR pathway. J. Cancer 2018, 9 (15), 2734-2742. DOI: 10.7150/jca.26374.

NLM

CSE

He D, Sun X, Yang H, Li X, Yang D. 2018. TOFA induces cell cycle arrest and apoptosis in ACHN and 786-O cells through inhibiting PI3K/Akt/mTOR pathway. J Cancer. 9(15):2734-2742.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.